Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV, Effect of Rennin-Angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria--- A Randomized Controlled Trial

NCT01500590 is registered in ClinicalTrials.gov with Hospital Authority, Hong Kong as lead sponsor.

NCT NCT01500590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV, Effect of Rennin-Angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With Normoalbuminuria--- A Randomized Controlled Trial
Lead sponsor
Hospital Authority, Hong Kong
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2011
Completion date
August 31, 2019
Enrollment
1,400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, hypertensive disease